Artificial tear solutions.
D000111:Acetylcysteine / Q000627:therapeutic use; D001548:Benzalkonium Compounds / Q000009:adverse effects; D002021:Buffers; D003263:Contact Lenses, Hydrophilic; D004355:Drug Stability; D005069:Evaluation Studies as Topic; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006982:Hypertonic Solutions / Q000009:adverse effects; D007038:Hypotonic Solutions / Q000009:adverse effects; D007637:Keratoconjunctivitis / Q000188:drug therapy*; D007765:Lacrimal Apparatus / Q000378:metabolism; D008153:Lubrication; D009077:Mucins / Q000378:metabolism; D009883:Ophthalmic Solutions / Q000627:therapeutic use*; D011108:Polymers / Q000627:therapeutic use; D012636:Secretory Rate; D013666:Tears / Q000378:metabolism; D013997:Time Factors
D001548:Benzalkonium Compounds; D002021:Buffers; D006982:Hypertonic Solutions; D007038:Hypotonic Solutions; D009077:Mucins; D009883:Ophthalmic Solutions; D011108:Polymers; D000111:Acetylcysteine